Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?

References

• BresslerNMBresslerSB2000Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciencesInvest Ophthalmol Vis Sci41624810711673
   PubMed Web of Science ®Google Scholar
• BresslerNM2001Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials – TAP Report 2Arch Ophthalmol11919820711176980
   PubMed Web of Science ®Google Scholar
• BresslerNM2002Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization – verteporfin in photodynamic therapy report 2Am J Ophthalmol133168911755871
   PubMed Web of Science ®Google Scholar
• BresslerSBBresslerNMFineSL1983Subfoveal neovascular membranes in senile macular degeneration. Relationship between membrane size and visual prognosisRetina3711
   Web of Science ®Google Scholar
• BusquetsMAShahGKWickensJ2003Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndromeRetina2329930612824828
   PubMed Web of Science ®Google Scholar
• ErgunEMaarNRadnerW2003Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degenerationOphthalmology11065912511348
   PubMed Web of Science ®Google Scholar
• FerrisIII FLFineSLHymanL1984Age-related macular degeneration and blindness due to neovascular maculopathyArch Ophthalmol102164026208888
   PubMed Web of Science ®Google Scholar
• FletcherDCSchuchardRA1997Preferred retinal loci: relationship to macular scotomas in a low-vision populationOphthalmology10463289111255
   PubMed Web of Science ®Google Scholar
• GassJDM1967aPathogenesis of disciform detachment of the neuroepithelium. III. Senile disciform macular degenerationAm J Ophthalmol6361744
   Web of Science ®Google Scholar
• GassJDM1967bPathogenesis of disciform detachment of the neuroepithelium. IV. Fluorescein angiographic study of senile disciform macular degenerationAm J Ophthalmol6364559
   Web of Science ®Google Scholar
• GhaziNGJabbourNMDe La CruzZC2001Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapyRetina214788611642377
   PubMed Web of Science ®Google Scholar
• GreenWREngerC1993Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman LectureOphthalmology1001519357692366
   PubMed Web of Science ®Google Scholar
• GreenWRKeySN3rd1977Senile macular degeneration: a histopathologic studyTrans Am Ophthalmol Soc75180254613523
   PubMedGoogle Scholar
• IshibashiTInomataHSakamotoT1995Pericytes of newly formed vessels in experimental subretinal neovascularizationArch Ophthalmol113227317864757
   PubMedGoogle Scholar
• IshibashiTRyanSJ1992Maturation of newly-formed subretinal vesselsEXS6159631377575
   PubMedGoogle Scholar
• KleinRWangQKleinBE1995The relationship of age-related maculopathy, cataract, and glaucoma to visual acuityInvest Ophthalmol Vis Sci36182917822146
   PubMed Web of Science ®Google Scholar
• [MPSG] Macular Photocoagulation Study Group1993Laser photocoagulation of subfoveal neovascular lesions of age-related macular degenerationArch Ophthalmol111120097689827
   PubMedGoogle Scholar
• MargherioRRMargherioARDeSantisME2000Laser treatment with verteporfin therapy and its potential impact on retinal practicesRetina203253010950407
   PubMed Web of Science ®Google Scholar
• MichelsSBarbazettoISchmidt-ErfurthU2000Choroidal changes after photodynamic therapy (PDT). A two year follow-up study of 38 patientsKlin Monatsbl Augenheilkd21794911022663
   PubMed Web of Science ®Google Scholar
• MidenaERadinPPPilottoE2004Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry studySemin Ophthalmol19556115590535
   PubMedGoogle Scholar
• OlkRJBurgessDBMcCormickPA1984Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosisOphthalmology9115926026084225
   PubMed Web of Science ®Google Scholar
• RoysterAJNandaSKHatchellDL1988Photochemical initiation of thrombosis. Fluorescein angiographic, histologic, and ultrastructural alterations in the choroid, retinal pigment epithelium and retinaArch Ophthalmol1061608143190547
   PubMedGoogle Scholar
• SapersteinDARosenfeldPJBresslerNMVerteporfin in Ocular Histoplasmosis (VOH) Study Group2002Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case seriesOphthalmology109149950512153802
   PubMed Web of Science ®Google Scholar
• Schmidt-ErfurthU1999Indocyanine green angiography and retinal sensitivity after photodynamic therapy of subfoveal choroidal neovascularizationSemin Ophthalmol14354410790573
   PubMedGoogle Scholar
• Schmidt-ErfurthUMElsnerHTeraiN2004Effects of verteporfin therapy on central visual field functionOphthalmology111931915121371
   PubMed Web of Science ®Google Scholar
• SchuchardRAFletcherDCAlbertDMJacobiecFA2000Preferred retinal locus and the scanning laser ophthalmoscopePrinciples and practice of ophthalmologySt. LowisWB Saunders Company2nd Ed2 Ch. 395543843
   Google Scholar
• SickenbergMSchmidt-ErfurthUMillerJW2000A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks and idiopathic causesArch Ophthalmol1183273610721954
   PubMedGoogle Scholar
• SoubraneGCoscasGJRyanSJWilkinsonCP2001Choroidal neovascularization in degenerative myopiaRetinaSt. LowisMosby3rd Ed2 Ch. 67113652
   Google Scholar
• SunnessJSApplegateCAHaselwoodD1996Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt diseaseOphthalmology1031458668841306
   PubMed Web of Science ®Google Scholar
• SuzukiHYoshidaK1998Electron microscopic study of capillary in the human renal cell carcinomaNippon Hinyokika Gakkai Zasshi8914229493417
   PubMedGoogle Scholar
• TeetersVWBirdAC1973A clinical study of the vascularity of senile disciform macular degenerationAm J Ophthalmol7553654684265
   PubMed Web of Science ®Google Scholar
• TimberlakeGTMainsterMAPeliE1986Reading with a macular scotoma. I. Retinal location of scotoma and fixation areaInvest Ophthalmol Vis Sci271137473721792
   PubMed Web of Science ®Google Scholar
• TimberlakeGTPeliEEssockEA1987Reading with a macular scotoma. II. Retinal locus for scanning textInvest Ophthalmol Vis Sci281268743610545
   PubMed Web of Science ®Google Scholar
• [TAP] Treatment of Age-Related Macular Degeneration With Photodynamic Therapy Study Group1999Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP Report 1Arch Ophthalmol11713294510532441
   PubMedGoogle Scholar
• [VIP] Verteporfin in Photodynamic Therapy Study Group2001aPhotodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial – VIP report no. 1Ophthalmology10884152
   Web of Science ®Google Scholar
• [VIP] Verteporfin In Photodynamic Therapy Study Group2001bVerteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization – verteporfin in photodynamic therapy (VIP) report 2Am J Ophthalmol13154160
   Web of Science ®Google Scholar
• [VIP] Verteporfin Roundtable 2000 and 2001 Participants, Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group Principal Investigators, Verteporfin In Photodynamic Therapy (VIP) Study Group Principal Investigators2002Guidelines for using verteporfin (Visudyne®) in photodynamic therapy to treat choroidal neovascularization secondary to age-related macular degeneration and other causesRetina2261811884872
   PubMed Web of Science ®Google Scholar
• VaranoMParisiVTedeschiM2005Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluationInvest Ophthalmol Vis Sci4614536215790915
   PubMed Web of Science ®Google Scholar
• von NoordenGKMackensenG1962Phenomenology of eccentric fixationAm J Ophthalmol536426113926696
   PubMed Web of Science ®Google Scholar
• WhittakerSGBuddJCummingsRW1988Eccentric fixation with macular scotomaInvest Ophthalmol Vis Sci29268783338884
   PubMed Web of Science ®Google Scholar
• YannuzziLANegraoSIidaT2001Retinal angiomatous proliferation in age-related macular degenerationRetina214163411642370
   PubMed Web of Science ®Google Scholar
• YodoiYTsujikawaAKamedaT2007Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathyAm J Ophthalmol1439849417336913
   PubMed Web of Science ®Google Scholar